Insider · CIK 0001960481
Jennifer Cote
Files at HBIO (HARVARD BIOSCIENCE INC). First filing -, latest -.
Jennifer Cote files SEC Form 4 as CFO at HBIO (HARVARD BIOSCIENCE INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jennifer Cote has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 19, 2025 | HBIO HARVARD BIOSCIENCE INC | FTax withholding Common Stock | -5,687 | $0.69 | $3,916 | 159,019 | Mar 21, 2025 |
| Dec 29, 2024 | HBIO HARVARD BIOSCIENCE INC | FTax withholding Common Stock | -4,731 | $1.98 | $9,367 | 164,007 | Dec 31, 2024 |
| Dec 29, 2024 | HBIO HARVARD BIOSCIENCE INC | FTax withholding Common Stock | -3,797 | $1.98 | $7,518 | 160,210 | Dec 31, 2024 |
Questions about Jennifer Cote
Answered from the filings on this page, as of the latest one.
Is Jennifer Cote buying or selling?
Jennifer Cote has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jennifer Cote's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jennifer Cote has 0.
Where does Jennifer Cote file Form 4?
Jennifer Cote has filed Form 4 at HBIO (HARVARD BIOSCIENCE INC) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.